Literature DB >> 7901908

Oxidative stress, glutamate, and neurodegenerative disorders.

J T Coyle1, P Puttfarcken.   

Abstract

There is an increasing amount of experimental evidence that oxidative stress is a causal, or at least an ancillary, factor in the neuropathology of several adult neurodegenerative disorders, as well as in stroke, trauma, and seizures. At the same time, excessive or persistent activation of glutamate-gated ion channels may cause neuronal degeneration in these same conditions. Glutamate and related acidic amino acids are thought to be the major excitatory neurotransmitters in brain and may be utilized by 40 percent of the synapses. Thus, two broad mechanisms--oxidative stress and excessive activation of glutamate receptors--are converging and represent sequential as well as interacting processes that provide a final common pathway for cell vulnerability in the brain. The broad distribution in brain of the processes regulating oxidative stress and mediating glutamatergic neurotransmission may explain the wide range of disorders in which both have been implicated. Yet differential expression of components of the processes in particular neuronal systems may account for selective neurodegeneration in certain disorders.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7901908     DOI: 10.1126/science.7901908

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  741 in total

1.  Unequal expression of allelic kainate receptor GluR7 mRNAs in human brains.

Authors:  H H Schiffer; G T Swanson; E Masliah; S F Heinemann
Journal:  J Neurosci       Date:  2000-12-15       Impact factor: 6.167

2.  The antioxidant neuroprotective effects of estrogens and phenolic compounds are independent from their estrogenic properties.

Authors:  B Moosmann; C Behl
Journal:  Proc Natl Acad Sci U S A       Date:  1999-08-03       Impact factor: 11.205

3.  Exacerbated responses to oxidative stress by an Na(+) load in isolated nerve terminals: the role of ATP depletion and rise of [Ca(2+)](i).

Authors:  C Chinopoulos; L Tretter; A Rozsa; V Adam-Vizi
Journal:  J Neurosci       Date:  2000-03-15       Impact factor: 6.167

4.  Experimentally activated immune defence in female pied flycatchers results in reduced breeding success.

Authors:  P Ilmonen; T Taarna; D Hasselquist
Journal:  Proc Biol Sci       Date:  2000-04-07       Impact factor: 5.349

Review 5.  Good genes, oxidative stress and condition-dependent sexual signals.

Authors:  T von Schantz; S Bensch; M Grahn; D Hasselquist; H Wittzell
Journal:  Proc Biol Sci       Date:  1999-01-07       Impact factor: 5.349

6.  NMDA and glutamate evoke excitotoxicity at distinct cellular locations in rat cortical neurons in vitro.

Authors:  J D Sinor; S Du; S Venneti; R C Blitzblau; D N Leszkiewicz; P A Rosenberg; E Aizenman
Journal:  J Neurosci       Date:  2000-12-01       Impact factor: 6.167

7.  Heat shock preconditioning and pretreatment with glucocorticoid antagonist RU 486 protect rat myogenic cells H9c2 against glutamate-induced cell death.

Authors:  E Gursoy; A Cardounel; M Kalimi
Journal:  Mol Cell Biochem       Date:  2001-04       Impact factor: 3.396

Review 8.  Pictorial review of glutamate excitotoxicity: fundamental concepts for neuroimaging.

Authors:  L P Mark; R W Prost; J L Ulmer; M M Smith; D L Daniels; J M Strottmann; W D Brown; L Hacein-Bey
Journal:  AJNR Am J Neuroradiol       Date:  2001 Nov-Dec       Impact factor: 3.825

9.  Different effects of lectins on the ligand binding of the NMDA receptors and sigma sites in rat brain hippocampus synaptic membranes.

Authors:  G G Machaidze; D Mikeladze
Journal:  Neurochem Res       Date:  2001-05       Impact factor: 3.996

10.  Coordinate regulation of glutathione biosynthesis and release by Nrf2-expressing glia potently protects neurons from oxidative stress.

Authors:  Andy Y Shih; Delinda A Johnson; Gloria Wong; Andrew D Kraft; Lei Jiang; Heidi Erb; Jeffrey A Johnson; Timothy H Murphy
Journal:  J Neurosci       Date:  2003-04-15       Impact factor: 6.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.